Pyrotinib Treatment in Patients With HER2+ Metastatic Breast Cancer and Brain Metastasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Clinical Cancer Research
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Pyrotinib Treatment in Patients With HER2-Positive Metastatic Breast Cancer and Brain Metastasis: Exploratory Final Analysis of Real-World, Multicenter Data
Clin. Cancer Res 2021 Jun 10;[EPub Ahead of Print], M Anwar, Q Chen, D Ouyang, S Wang, N Xie, Q Ouyang, P Fan, L Qian, G Chen, E Zhou, L Guo, X Gu, B Ding, X Yang, L Liu, C Deng, Z Xiao, J Li, Y Wang, S Zeng, J Hu, W Zhou, B Qiu, Z Wang, J Weng, M Liu, Y Li, T Tang, J Wang, H Zhang, B Dai, W Tang, T Wu, M Xiao, X Li, H Liu, L Li, W YiFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Brain Cancer Center of Excellence
Visit our Brain Cancer Center of Excellence for additional, in-depth coverage.